Similar articles

• Rationale of heparin in the treatment of thromboembolic disease.

  LOEWE L. LOEWE L. Interne. 1947 Nov;13(11):493; passim. Interne. 1947. PMID: 18897566 No abstract available.
• [Indications of heparin in cardiology].

  BEAUMONT JL. BEAUMONT JL. Pathol Biol. 1960 May;8:999-1002. Pathol Biol. 1960. PMID: 13797979 French. No abstract available.
• [Recent advances in the treatment of thromboembolic conditions with heparin and dicoumarin].

  BARAC G. BARAC G. Rev Med Liege. 1947 May 15;2(10):266-73. Rev Med Liege. 1947. PMID: 20263780 French. No abstract available.
• [Anticoagulants in cardiovascular diseases].

  MAYALL R. MAYALL R. Rev Bras Med. 1953 Feb;10(2):109-11. Rev Bras Med. 1953. PMID: 13074757 Undetermined Language. No abstract available.
• Antithrombotic drugs: part I.

  Gallus AS, Hirsh J. Gallus AS, et al. Drugs. 1976;12(1):41-68. doi: 10.2165/00003495-197612010-00002. Drugs. 1976. PMID: 789043 Review.